Fortrea is a leading global contract research organization (CRO) spun off from Labcorp in 2023, providing Phase I through IV clinical trial management, clinical pharmacology, and market access solutions for biopharma and MedTech companies. While Fortrea has some onsite Phase I manufacturing capability for small molecule clinical supplies, its core business is clinical trial services, not contract drug manufacturing.
Clinical trial management, clinical pharmacology, bioanalytical services, regulatory consulting, Phase I-IV studies
1 site worldwide
Involvement in 2 clinical trials
No certifications on file yet.
No reviews available yet.
No documents available.